Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation TherapyHusain Yar Khan(Wayne State University), Asfar S. Azmi(The Barbara Ann Karmanos Cancer Institute)Advances in Radiation OncologyNovember 9, 202210.1016/j.adro.2022.101122Cited by 20SaveCiteExport RISWatch citationsRelated PapersTargeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition|Scientific Reports|2015|36Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression|Oncotarget|2018|17Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of <i>KRAS</i> G12C-Mutant Pancreatic and Lung Cancers|Molecular Cancer Therapeutics|2023|12